30 Aug Health Ascimib (Asciminib): A Breakthrough in CML Treatment 30/08/2025 By Dipesh Ascimib, containing the active ingredient asciminib, is a targeted therapy approved for the treatment of Philadelphia chromosome-positi...Continue reading